Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
Clinical trial NCT06007092 · RECRUITING
Trial details
- NCT number
- NCT06007092
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2025-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.